Patents by Inventor Andrew V. Halpert

Andrew V. Halpert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230414871
    Abstract: A fluid therapy method for an ADHF patient includes setting a urine output rate desired threshold, setting one or more desired negative net gain rates, and optionally setting a total fluid loss goal. The urine output of the patient is monitored and fluid is automatically administered to the patient at increasing rates to equal to or approximately match the patient's increasing urine output rates until the patient's urine output rate reaches the set urine output rate desired threshold. Thereafter, fluid is administered to the patient at rates to achieve the set desired negative net gain rate until the fluid loss goal is reached. Thereafter, until the end of therapy, fluid is administered to the patient at rates equal to or approximately equal to the monitored urine output rates.
    Type: Application
    Filed: May 23, 2023
    Publication date: December 28, 2023
    Inventors: Andrew V. Halpert, Mark Tauscher, Mark Gelfand, Howard Levin
  • Patent number: 11696985
    Abstract: A fluid therapy method for an ADHF patient includes setting a urine output rate desired threshold, setting one or more desired negative net gain rates, and optionally setting a total fluid loss goal. The urine output of the patient is monitored and fluid is automatically administered to the patient at increasing rates to equal to or approximately match the patient's increasing urine output rates until the patient's urine output rate reaches the set urine output rate desired threshold. Thereafter, fluid is administered to the patient at rates to achieve the set desired negative net gain rate until the fluid loss goal is reached. Thereafter, until the end of therapy, fluid is administered to the patient at rates equal to or approximately equal to the monitored urine output rates.
    Type: Grant
    Filed: April 30, 2020
    Date of Patent: July 11, 2023
    Assignee: Reprieve Cardiovascular, Inc.
    Inventors: Andrew V. Halpert, Mark Tauscher, Mark Gelfand, Howard Levin
  • Publication number: 20220152302
    Abstract: A fluid therapy method for an ADHF patient includes setting a urine output rate desired threshold, setting one or more desired negative net gain rates, and optionally setting a total fluid loss goal. The urine output of the patient is monitored and fluid is automatically administered to the patient at increasing rates to equal to or approximately match the patient's increasing urine output rates until the patient's urine output rate reaches the set urine output rate desired threshold. Thereafter, fluid is administered to the patient at rates to achieve the set desired negative net gain rate until the fluid loss goal is reached. Thereafter, until the end of therapy, fluid is administered to the patient at rates equal to or approximately equal to the monitored urine output rates.
    Type: Application
    Filed: November 24, 2021
    Publication date: May 19, 2022
    Inventors: Andrew V. HALPERT, Mark TAUSCHER, Mark GELFAND, Howard LEVIN
  • Patent number: 11213621
    Abstract: A fluid therapy method for an ADHF patient includes setting a urine output rate desired threshold, setting one or more desired negative net gain rates, and optionally setting a total fluid loss goal. The urine output of the patient is monitored and fluid is automatically administered to the patient at increasing rates to equal to or approximately match the patient's increasing urine output rates until the patient's urine output rate reaches the set urine output rate desired threshold. Thereafter, fluid is administered to the patient at rates to achieve the set desired negative net gain rate until the fluid loss goal is reached. Thereafter, until the end of therapy, fluid is administered to the patient at rates equal to or approximately equal to the monitored urine output rates.
    Type: Grant
    Filed: October 5, 2018
    Date of Patent: January 4, 2022
    Assignee: Reprieve Cardiovascular, Inc.
    Inventors: Andrew V. Halpert, Mark Tauscher, Mark Gelfand, Howard Levin
  • Publication number: 20210378589
    Abstract: A fluid replacement method including: determining the amount of urine expelled by a patient; infusing via a pump fluid from a first fluid source into a patient; determining an amount of fluid infused into the patient from the first fluid source; adjusting the operating of the pump based on the determined amount of urine expelled and the amount of fluid infused into the patient; setting a desired fluid balance for the patient; setting an amount of at least one additional fluid delivered to the patient, wherein the at least one additional fluid is not pumped into the patient; calculating an actual fluid balance based on the determined urine output, the determined amount of fluid infused into the patient from the first fluid source, and the set amount of said at least one additional fluid delivered to the patient; and automatically controlling the pump based on the actual fluid balance and the set desired fluid balance so the actual fluid balance conforms to the desired fluid balance.
    Type: Application
    Filed: June 25, 2021
    Publication date: December 9, 2021
    Inventors: J. Richardo Da Silva, Wieslaw Gronek, Andrew V. Halpert, Robert I. Rudko, Mark Tauscher
  • Patent number: 11064939
    Abstract: A fluid replacement method including: determining the amount of urine expelled by a patient; infusing via a pump fluid from a first fluid source into a patient; determining an amount of fluid infused into the patient from the first fluid source; adjusting the operating of the pump based on the determined amount of urine expelled and the amount of fluid infused into the patient; setting a desired fluid balance for the patient; setting an amount of at least one additional fluid delivered to the patient, wherein the at least one additional fluid is not pumped into the patient; calculating an actual fluid balance based on the determined urine output, the determined amount of fluid infused into the patient from the first fluid source, and the set amount of said at least one additional fluid delivered to the patient; and automatically controlling the pump based on the actual fluid balance and the set desired fluid balance so the actual fluid balance conforms to the desired fluid balance.
    Type: Grant
    Filed: August 2, 2018
    Date of Patent: July 20, 2021
    Assignee: Reprieve Cardiovascular, Inc.
    Inventors: J. Ricardo Da Silva, Wieslaw Gronek, Andrew V. Halpert, Robert I. Rudko, Mark Tauscher
  • Publication number: 20200254178
    Abstract: A fluid therapy method for an ADHF patient includes setting a urine output rate desired threshold, setting one or more desired negative net gain rates, and optionally setting a total fluid loss goal. The urine output of the patient is monitored and fluid is automatically administered to the patient at increasing rates to equal to or approximately match the patient's increasing urine output rates until the patient's urine output rate reaches the set urine output rate desired threshold. Thereafter, fluid is administered to the patient at rates to achieve the set desired negative net gain rate until the fluid loss goal is reached. Thereafter, until the end of therapy, fluid is administered to the patient at rates equal to or approximately equal to the monitored urine output rates.
    Type: Application
    Filed: April 30, 2020
    Publication date: August 13, 2020
    Inventors: Andrew V. HALPERT, Mark TAUSCHER, Mark GELFAND, Howard LEVIN
  • Patent number: 10639419
    Abstract: A fluid therapy method for an ADHF patient includes setting a urine output rate desired threshold, setting one or more desired negative net gain rates, and optionally setting a total fluid loss goal. The urine output of the patient is monitored and fluid is automatically administered to the patient at increasing rates to equal to or approximately match the patient's increasing urine output rates until the patient's urine output rate reaches the set urine output rate desired threshold. Thereafter, fluid is administered to the patient at rates to achieve the set desired negative net gain rate until the fluid loss goal is reached. Thereafter, until the end of therapy, fluid is administered to the patient at rates equal to or approximately equal to the monitored urine output rates.
    Type: Grant
    Filed: July 11, 2018
    Date of Patent: May 5, 2020
    Assignee: PLC MEDICAL SYSTEMS, INC.
    Inventors: Andrew V. Halpert, Mark Tauscher, Mark Gelfand, Howard Levin
  • Publication number: 20180338718
    Abstract: A fluid replacement method including: determining the amount of urine expelled by a patient; infusing via a pump fluid from a first fluid source into a patient; determining an amount of fluid infused into the patient from the first fluid source; adjusting the operating of the pump based on the determined amount of urine expelled and the amount of fluid infused into the patient; setting a desired fluid balance for the patient; setting an amount of at least one additional fluid delivered to the patient, wherein the at least one additional fluid is not pumped into the patient; calculating an actual fluid balance based on the determined urine output, the determined amount of fluid infused into the patient from the first fluid source, and the set amount of said at least one additional fluid delivered to the patient; and automatically controlling the pump based on the actual fluid balance and the set desired fluid balance so the actual fluid balance conforms to the desired fluid balance.
    Type: Application
    Filed: August 2, 2018
    Publication date: November 29, 2018
    Inventors: J. Ricardo DA SILVA, Wieslaw Gronek, Andrew V. Halpert, Robert I. Rudko, Mark Tauscher
  • Publication number: 20180326151
    Abstract: A fluid therapy method for an ADHF patient includes setting a urine output rate desired threshold, setting one or more desired negative net gain rates, and optionally setting a total fluid loss goal. The urine output of the patient is monitored and fluid is automatically administered to the patient at increasing rates to equal to or approximately match the patient's increasing urine output rates until the patient's urine output rate reaches the set urine output rate desired threshold. Thereafter, fluid is administered to the patient at rates to achieve the set desired negative net gain rate until the fluid loss goal is reached. Thereafter, until the end of therapy, fluid is administered to the patient at rates equal to or approximately equal to the monitored urine output rates.
    Type: Application
    Filed: July 11, 2018
    Publication date: November 15, 2018
    Inventors: Andrew V. HALPERT, Mark TAUSCHER, Mark GELFAND, Howard LEVIN
  • Patent number: 10045734
    Abstract: A console includes a weighing subsystem responsive to a first fluid source and a urine collection chamber. A pump infuses fluid from the first fluid source into a patient. A processing subsystem is responsive to the weighing subsystem. Based on the weight of the first fluid source and of the urine collection chamber, urine output and amount of fluid infused into the patient from the first fluid source are determined. A user can set a desired fluid balance and the amount of at least one additional fluid delivered. An actual fluid balance is calculated based on the determined urine output, the determined amount of fluid infused from the first fluid source, and the set amount of the additional fluid delivered. The pump is controlled based on actual fluid balance and set desired fluid balance so actual fluid balance becomes the same or approximately the same as the desired fluid balance.
    Type: Grant
    Filed: January 14, 2010
    Date of Patent: August 14, 2018
    Assignee: PLC Medical Systems, Inc.
    Inventors: J. Ricardo Da Silva, Wieslaw Gronek, Andrew V. Halpert, Robert I. Rudko, Mark Tauscher
  • Publication number: 20180185577
    Abstract: A fluid therapy method for an ADHF patient includes setting a urine output rate desired threshold, setting one or more desired negative net gain rates, and optionally setting a total fluid loss goal. The urine output of the patient is monitored and fluid is automatically administered to the patient at increasing rates to equal to or approximately match the patient's increasing urine output rates until the patient's urine output rate reaches the set urine output rate desired threshold. Thereafter, fluid is administered to the patient at rates to achieve the set desired negative net gain rate until the fluid loss goal is reached. Thereafter, until the end of therapy, fluid is administered to the patient at rates equal to or approximately equal to the monitored urine output rates.
    Type: Application
    Filed: March 12, 2015
    Publication date: July 5, 2018
    Inventors: Andrew V. Halpert, Mark Tauscher, MARK GELFAND, HOWARD LEVIN
  • Publication number: 20180071455
    Abstract: A fluid therapy method for an ADHF patient includes setting a urine output rate desired threshold, setting one or more desired negative net gain rates, and optionally setting a total fluid loss goal. The urine output of the patient is monitored and fluid is automatically administered to the patient at increasing rates to equal to or approximately match the patient's increasing urine output rates until the patient's urine output rate reaches the set urine output rate desired threshold. Thereafter, fluid is administered to the patient at rates to achieve the set desired negative net gain rate until the fluid loss goal is reached. Thereafter, until the end of therapy, fluid is administered to the patient at rates equal to or approximately equal to the monitored urine output rates.
    Type: Application
    Filed: March 12, 2015
    Publication date: March 15, 2018
    Inventors: Andrew V. Halpert, Mark Tauscher, MARK GELFAND, HOWARD LEVIN
  • Publication number: 20150258277
    Abstract: A fluid therapy method for an ADHF patient includes setting a urine output rate desired threshold, setting one or more desired negative net gain rates, and optionally setting a total fluid loss goal. The urine output of the patient is monitored and fluid is automatically administered to the patient at increasing rates to equal to or approximately match the patient's increasing urine output rates until the patient's urine output rate reaches the set urine output rate desired threshold. Thereafter, fluid is administered to the patient at rates to achieve the set desired negative net gain rate until the fluid loss goal is reached. Thereafter, until the end of therapy, fluid is administered to the patient at rates equal to or approximately equal to the monitored urine output rates.
    Type: Application
    Filed: March 12, 2015
    Publication date: September 17, 2015
    Inventors: Andrew V. Halpert, Mark Tauscher
  • Patent number: 8968231
    Abstract: An extracorporeal blood circuit including: a withdrawal conduit connectable to a coronary withdrawal catheter; a withdrawal pump connectable to the withdrawal conduit, wherein a pumping rate of the withdrawal pump determines a blood withdrawal rate from the coronary withdrawal catheter; a filter having an input connected to the withdrawal conduit and a blood output connected to an infusion conduit and a filtrate output connected to a filtrate conduit; a filtrate measurement device to determine an amount of filtrate removed from the blood in the filter; a fluid supplementation conduit providing a blood replacement fluid to at least one of the withdrawal conduit, filter and infusion conduit; a supplementation pump connectable to the fluid supplementation conduit, wherein a pumping rate of the supplementation pump determines a rate at which the blood replacement fluid flows into the blood flowing through the blood circuit, and a controller regulating the pumping rate of the supplementation pump such that the rat
    Type: Grant
    Filed: July 22, 2013
    Date of Patent: March 3, 2015
    Assignee: Gambro UF Solutions, Inc.
    Inventors: Steven J. Bernard, John J. O'Mahony, Andrew V. Halpert, Mark Gelfand, Howard R. Levin
  • Publication number: 20140094732
    Abstract: An extracorporeal blood circuit including: a withdrawal conduit connectable to a coronary withdrawal catheter; a withdrawal pump connectable to the withdrawal conduit, wherein a pumping rate of the withdrawal pump determines a blood withdrawal rate from the coronary withdrawal catheter; a filter having an input connected to the withdrawal conduit and a blood output connected to an infusion conduit and a filtrate output connected to a filtrate conduit; a filtrate measurement device to determine an amount of filtrate removed from the blood in the filter; a fluid supplementation conduit providing a blood replacement fluid to at least one of the withdrawal conduit, filter and infusion conduit; a supplementation pump connectable to the fluid supplementation conduit, wherein a pumping rate of the supplementation pump determines a rate at which the blood replacement fluid flows into the blood flowing through the blood circuit, and a controller regulating the pumping rate of the supplementation pump such that the rat
    Type: Application
    Filed: July 22, 2013
    Publication date: April 3, 2014
    Applicant: CHF Solutions, Inc.
    Inventors: Steven J. BERNARD, John J. O'Mahony, Andrew V. Halpert, Mark Gelfand, Howard R. Levin
  • Patent number: 8506511
    Abstract: An extracorporeal blood circuit including: a withdrawal conduit connectable to a coronary withdrawal catheter; a withdrawal pump connectable to the withdrawal conduit, wherein a pumping rate of the withdrawal pump determines a blood withdrawal rate from the coronary withdrawal catheter; a filter having an input connected to the withdrawal conduit and a blood output connected to an infusion conduit and a filtrate output connected to a filtrate conduit; a filtrate measurement device to determine an amount of filtrate removed from the blood in the filter; a fluid supplementation conduit providing a blood replacement fluid to at least one of the withdrawal conduit, filter and infusion conduit; a supplementation pump connectable to the fluid supplementation conduit, wherein a pumping rate of the supplementation pump determines a rate at which the blood replacement fluid flows into the blood flowing through the blood circuit, and a controller regulating the pumping rate of the supplementation pump such that the rat
    Type: Grant
    Filed: January 5, 2007
    Date of Patent: August 13, 2013
    Assignee: Gambro UF Solutions, Inc.
    Inventors: Steven J. Bernard, John J. O'Mahony, Andrew V. Halpert, Mark Gelfand, Howard R. Levin
  • Publication number: 20100274217
    Abstract: A fluid replacement device and method. A console includes a weighing subsystem responsive to a first fluid source and a urine collection chamber. A pump is configured to infuse fluid from the first fluid source into a patient. A processing subsystem in the console is responsive to the weighing subsystem. Based on the weight of the first fluid source and the weight of the urine collection chamber, the patient's urine output and the amount of fluid infused into the patient from the first fluid source are determined. A user interface in the console allows the user to set a desired fluid balance for the patient and the amount of at least one additional fluid delivered to the patient. An actual fluid balance is calculated based on the determined urine output, the determined amount of fluid infused into the patient from the first fluid source, and the set amount of the at least one additional fluid delivered to the patient.
    Type: Application
    Filed: January 14, 2010
    Publication date: October 28, 2010
    Inventors: J. Ricardo Da Silva, Wieslaw Gronek, Andrew V. Halpert, Robert I. Rudko, Mark Tauscher
  • Patent number: 7727222
    Abstract: A patient hydration system with an infusion subsystem which infuses fluid into a patient and a urine output measurement subsystem for measuring the amount of urine output by the patient. A controller is configured to control the infusion subsystem and is responsive to the urine output measurement subsystem. The controller includes a balancing function which controls the infusion subsystem to administer fluid infused into the patient to balance the urine output with the fluid infusion. The controller also includes a taper down function which controls the infusion subsystem to administer fluid infused into the patient at a rate less than the rate of urine output by the patient.
    Type: Grant
    Filed: May 20, 2008
    Date of Patent: June 1, 2010
    Assignee: PLC Medical Systems, Inc.
    Inventors: J. Ricardo Da Silva, Wieslaw Gronek, Andrew V. Halpert, Kenneth John Luppi, Robert I. Rudko, Mark Tauscher
  • Patent number: 7462786
    Abstract: A weight scale including: a measuring electronic circuit including a filter; a load cell attachable to a support housing and generating a load signal processed by the filter of the electronic circuit; a spring coupled to the load cell to apply a force to the load cell, wherein the load signal is indicative of the force, and a scale beam connected to the spring and to the support housing, wherein a weight to be measured is attached to the scale beam and the force applied by the spring is indicative of the weight, and wherein natural frequencies of the weight and spring is higher than a cut-off frequency of the filter.
    Type: Grant
    Filed: March 7, 2007
    Date of Patent: December 9, 2008
    Assignee: CHF Solutions, Inc.
    Inventors: John J. O'Mahony, Sonny Behan, Andrew V. Halpert, Edward G. Rychlick